Enfermedad pulmonar post-tuberculosis (PTLD): perspectivas clínicas, funcionales y sociales

: tablas, figuras

Autores:
Giraldo Montoya, Angela María
García Castro, Giovanni
García Giraldo, Laura Sofia
Sierra Garzón, Luisa Fernanda
Fernández Cabrera, Gloria Stefany
Martínez, José William
Ordoñez Díaz, Karen Melissa
Giraldo Diaconeasa, Adrián
Giraldo Gómez, Jenifer
Tipo de recurso:
Book
Fecha de publicación:
2025
Institución:
Universidad Tecnológica de Pereira
Repositorio:
Repositorio Institucional UTP
Idioma:
spa
OAI Identifier:
oai:repositorio.utp.edu.co:11059/16449
Acceso en línea:
https://hdl.handle.net/11059/16449
https://doi.org/10.22517/9786285010668
https://repositorio.utp.edu.co/home
Palabra clave:
610 - Medicina y salud::616 - Enfermedades
Enfermedades transmisibles
Infecciones respiratorias
Medicina - Investigaciones
3. Ciencias Médicas y de la Salud
Enfermedades infecciosas
Enfermedades respiratorias
Tuberculosis
Medicina – Investigaciones
ODS 3: Salud y bienestar. Garantizar una vida sana y promover el bienestar de todos a todas las edades
Rights
openAccess
License
Atribución-NoComercial-SinDerivadas 4.0 Internacional (CC BY-NC-ND 4.0)
id UTP2_b799fbb3f85f6d2764d3aecbdaf3a7ed
oai_identifier_str oai:repositorio.utp.edu.co:11059/16449
network_acronym_str UTP2
network_name_str Repositorio Institucional UTP
repository_id_str
dc.title.spa.fl_str_mv Enfermedad pulmonar post-tuberculosis (PTLD): perspectivas clínicas, funcionales y sociales
title Enfermedad pulmonar post-tuberculosis (PTLD): perspectivas clínicas, funcionales y sociales
spellingShingle Enfermedad pulmonar post-tuberculosis (PTLD): perspectivas clínicas, funcionales y sociales
610 - Medicina y salud::616 - Enfermedades
Enfermedades transmisibles
Infecciones respiratorias
Medicina - Investigaciones
3. Ciencias Médicas y de la Salud
Enfermedades infecciosas
Enfermedades respiratorias
Tuberculosis
Medicina – Investigaciones
ODS 3: Salud y bienestar. Garantizar una vida sana y promover el bienestar de todos a todas las edades
title_short Enfermedad pulmonar post-tuberculosis (PTLD): perspectivas clínicas, funcionales y sociales
title_full Enfermedad pulmonar post-tuberculosis (PTLD): perspectivas clínicas, funcionales y sociales
title_fullStr Enfermedad pulmonar post-tuberculosis (PTLD): perspectivas clínicas, funcionales y sociales
title_full_unstemmed Enfermedad pulmonar post-tuberculosis (PTLD): perspectivas clínicas, funcionales y sociales
title_sort Enfermedad pulmonar post-tuberculosis (PTLD): perspectivas clínicas, funcionales y sociales
dc.creator.fl_str_mv Giraldo Montoya, Angela María
García Castro, Giovanni
García Giraldo, Laura Sofia
Sierra Garzón, Luisa Fernanda
Fernández Cabrera, Gloria Stefany
Martínez, José William
Ordoñez Díaz, Karen Melissa
Giraldo Diaconeasa, Adrián
Giraldo Gómez, Jenifer
dc.contributor.author.none.fl_str_mv Giraldo Montoya, Angela María
García Castro, Giovanni
García Giraldo, Laura Sofia
Sierra Garzón, Luisa Fernanda
Fernández Cabrera, Gloria Stefany
Martínez, José William
Ordoñez Díaz, Karen Melissa
Giraldo Diaconeasa, Adrián
Giraldo Gómez, Jenifer
dc.subject.ddc.none.fl_str_mv 610 - Medicina y salud::616 - Enfermedades
topic 610 - Medicina y salud::616 - Enfermedades
Enfermedades transmisibles
Infecciones respiratorias
Medicina - Investigaciones
3. Ciencias Médicas y de la Salud
Enfermedades infecciosas
Enfermedades respiratorias
Tuberculosis
Medicina – Investigaciones
ODS 3: Salud y bienestar. Garantizar una vida sana y promover el bienestar de todos a todas las edades
dc.subject.armarc.none.fl_str_mv Enfermedades transmisibles
Infecciones respiratorias
Medicina - Investigaciones
dc.subject.ocde.none.fl_str_mv 3. Ciencias Médicas y de la Salud
dc.subject.proposal.spa.fl_str_mv Enfermedades infecciosas
Enfermedades respiratorias
Tuberculosis
Medicina – Investigaciones
dc.subject.ods.none.fl_str_mv ODS 3: Salud y bienestar. Garantizar una vida sana y promover el bienestar de todos a todas las edades
description : tablas, figuras
publishDate 2025
dc.date.accessioned.none.fl_str_mv 2025-11-10T20:00:31Z
dc.date.available.none.fl_str_mv 2025-11-10T20:00:31Z
dc.date.issued.none.fl_str_mv 2025
dc.type.none.fl_str_mv Libro
dc.type.version.none.fl_str_mv info:eu-repo/semantics/acceptedVersion
dc.type.coar.none.fl_str_mv http://purl.org/coar/resource_type/c_2f33
dc.type.content.none.fl_str_mv Text
dc.type.driver.none.fl_str_mv info:eu-repo/semantics/book
format http://purl.org/coar/resource_type/c_2f33
status_str acceptedVersion
dc.identifier.citation.spa.fl_str_mv Giraldo Montoya, A, García Castro, G, García Giraldo, L, Sierra Garzón, L, Fernández Cabrera, G, Martínez, J, Ordoñez Díaz, K, Giraldo Diaconeasa, A y Giraldo Gómez, J. (2025). Enfermedad pulmonar post-tuberculosis (PTLD): perspectivas clínicas, funcionales y sociales. Universidad Tecnológica de Pereira. Disponible en: https://hdl.handle.net/11059/16449
dc.identifier.uri.none.fl_str_mv https://hdl.handle.net/11059/16449
dc.identifier.eisbn.none.fl_str_mv 978-628-501-066-8
dc.identifier.doi.spa.fl_str_mv https://doi.org/10.22517/9786285010668
dc.identifier.instname.none.fl_str_mv Universidad Tecnológica de Pereira
dc.identifier.reponame.none.fl_str_mv Repositorio Universidad Tecnológica de Pereira
dc.identifier.repourl.none.fl_str_mv https://repositorio.utp.edu.co/home
identifier_str_mv Giraldo Montoya, A, García Castro, G, García Giraldo, L, Sierra Garzón, L, Fernández Cabrera, G, Martínez, J, Ordoñez Díaz, K, Giraldo Diaconeasa, A y Giraldo Gómez, J. (2025). Enfermedad pulmonar post-tuberculosis (PTLD): perspectivas clínicas, funcionales y sociales. Universidad Tecnológica de Pereira. Disponible en: https://hdl.handle.net/11059/16449
978-628-501-066-8
Universidad Tecnológica de Pereira
Repositorio Universidad Tecnológica de Pereira
url https://hdl.handle.net/11059/16449
https://doi.org/10.22517/9786285010668
https://repositorio.utp.edu.co/home
dc.language.iso.none.fl_str_mv spa
language spa
dc.relation.ispartofseries.spa.fl_str_mv Colección Trabajos de Investigación
dc.relation.references.none.fl_str_mv 1. World Health Organization. Global tuberculosis report 2023. Geneva: WHO; 2023. Disponible en: https://www.who.int/publications/i/ item/9789240083851
2. Romanowski K, Baumann B, Basham CA, Khan FA, Fox GJ, Johnston JC. Long-term all-cause mortality in people treated for tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis. 2019;19(10):1129–37. doi:10.1016/S1473-3099(19)30309-3
3. Migliori GB, Centis R, D’Ambrosio L, Tiberi S, Zumla A. Multidrug- resistant tuberculosis and extensively drug-resistant tuberculosis. Eur Respir J. 2021;57(6):2100633. doi:10.1183/13993003.00633- 2021
4. Allwood BW, Byrne A, Meghji J, Rachow A, van der Zalm MM, Schoch OD, et al. Post-tuberculosis lung health: perspectives from the First International Symposium. Int J Tuberc Lung Dis. 2020;24(8):820–8. doi:10.5588/ijtld.20.0067
5. Byrne AL, Marais BJ, Mitnick CD, Lecca L, Marks GB. Chronic airflow obstruction after successful treatment of tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis. 2015;15(8):905–13. doi:10.1016/S1473-3099(15)00037-7
6. World Health Organization. Roadmap towards ending TB in children and adolescents. 2nd ed. Geneva: WHO; 2023.
7. Dheda K, Ruhwald M, Theron G, Peter J, Yam WC. The WHO definition of post-tuberculosis lung disease: improving data for care, research, and policy. Lancet Respir Med. 2021;9(9):839–46. doi:10.1016/S2213-2600(21)00254-8
8. Meghji J, Simpson H, Squire SB, Mortimer K. The long-term effect of pulmonary tuberculosis on lung function: a systematic review and meta-analysis. Thorax. 2016;71(10):849–61. doi:10.1136/ thoraxjnl-2015-207491
9. Mpagama SG, Kibiki GS, Ulenga N, Mbelele P, Lema LE, Semvua HH, et al. The prevalence and pattern of post-tuberculosis lung disease in patients who successfully completed TB treatment. BMC Pulm Med. 2025; 25:3549. doi:10.1186/s12890-025-03549-5
10. Allwood BW, van der Zalm MM, Meintjes G, Maartens G, Warren R, Dheda K, et al. Post-tuberculosis lung disease: addressing the policy gap. PLOS Glob Public Health. 2023;3(8): e0003560. doi:10.1371/journal.pgph.0003560
11. Seneviratne S, Rathnayake D, Wijesinghe A, de Silva S, Jayasuriya R. Validation of FACIT-TB for assessing quality of life in post-TB patients. Appl Res Qual Life. 2022;17(2):579–92. doi:10.1007/ s11482-021-09927-5
12. Bhattacharyya P, Datta D, Saha D, Paul R, Mitra DK. Tuberculosis- associated pulmonary hypertension: the revelation of a clinical observation. Lung India. 2016;33(2):135. doi:10.4103/0970- 2113.177433
13. Shrestha A, Aryal S, Sharma S, Adhikari J. Artificial intelligence in tuberculosis imaging: current status and future directions. J Thorac Dis. 2023;15(2):423–35. doi:10.21037/jtd-22-917
14. Migliori GB, Duarte R, Tiberi S, Zumla A. Tuberculosis: the new challenges. Eur Respir Rev. 2022;31(165):220063. doi:10.1183/16000617.0063-2022
1. World Health Organization. Global tuberculosis report 2021. Geneva: WHO; 2021.
2. Meghji J, Lesosky M, Joekes E, Banda P, Rylance J, Gordon SB, et al. Patient outcomes associated with post-TB lung damage in Malawi: a prospective cohort study. Thorax. 2020; 75(3):269–78.
3. Hnizdo E, Singh T, Churchyard G. Chronic pulmonary function impairment caused by initial and recurrent pulmonary tuberculosis following treatment. Thorax. 2000;55(1):32–8.
4. Pasipanodya JG, Miller TL, Vecino M, Munguia G, Bae S, Drewyer G, et al. Pulmonary impairment after tuberculosis. Chest. 2007;131(6):1817–24.
5. Allwood BW, Byrne A, Meghji J, Rachow A, van der Zalm MM, Schoch OD, et al. Post-tuberculosis lung disease: Clinical review of an under-recognised global challenge. Lancet Glob Health. 2021;9(12): e1670–8.
6. van Kampen SC, Wanner A, Edwards M, Harries AD, Kirenga BJ, Chakaya JM, et al. International research and guidelines on post- tuberculosis chronic lung disorders: A systematic scoping review. BMJ Glob Health. 2018;3(4): e000745.
7. Datta S, Evans CA. Post-tuberculosis lung disease: the next global epidemic. Lancet Glob Health. 2019;7(12): e1678–9.
8. Liu CH, Liu H, Ge B. Innate immunity in tuberculosis: host defense vs pathogen evasion. Cell Mol Immunol. 2017;14(12):963–75.
9. Ramakrishnan L. Revisiting the role of the granuloma in tuberculosis. Nat Rev Immunol. 2012; 12(5):352–66.
10. Saunders BM, Britton WJ. Life and death in the granuloma: immunopathology of tuberculosis. Immunol Cell Biol. 2007; 85(2):103–11.
11. Lawn SD, Zumla AI. Tuberculosis. Lancet. 2011;378(9785):57–72.
12. Sia IG, Wieland ML. Current concepts in the management of tuberculosis. Mayo Clin Proc. 2011; 86(4):348–61.
13. Ulrichs T, Kaufmann SH. New insights into the function of granulomas in human tuberculosis. J Pathol. 2006; 208(2):261–9.
14. Elkington PT, Friedland JS. Matrix metalloproteinases in destructive pulmonary pathology. Thorax. 2006; 61(3):259–66.
15. Esmail H, Barry CE 3rd, Young DB, Wilkinson RJ. The ongoing challenge of latent tuberculosis. Philos Trans R Soc Lond B Biol Sci. 2014;369(1645):20130437.
16. Hunter RL. Pathology of post primary tuberculosis of the lung: an illustrated critical review. Tuberculosis. 2011; 91(6):497–509.
17. Narasimhan P, Wood J, MacIntyre CR, Mathai D. Risk factors for tuberculosis. Pulm Med. 2013; 2013:828939.
18. Sharma SK, Mohan A. Tuberculosis: from an incurable scourge to a curable disease - journey over a millennium. Indian J Med Res. 2013; 137(3):455–93.
19. Lawn SD, Zumla AI. Tuberculosis. Lancet. 2011; 378(9785):57–72.
20. Naing C, Mak JW, Maung M, Wong SF, Kassim AI. Meta-analysis: the association between HIV infection and extrapulmonary tuberculosis. Lung. 2013; 191(1):27–34.
21. Lee KS, Song KS, Lim TH, Kim PN, Kim IY, Lee BH. Adult-onset pulmonary tuberculosis: findings on chest radiographs and CT scans. AJR Am J Roentgenol. 1993; 160(4):753–8.
22. Meghji J, Lesosky M, Joekes E, Banda P, Rylance J, Gordon S, et al. Patient outcomes associated with post-tuberculosis lung damage in Malawi: a prospective cohort study. Thorax. 2020; 75(3):269–78.
23. Allwood BW, Byrne A, Meghji J, Rachow A, van der Zalm MM, Schoch OD, et al. Post-tuberculosis lung disease: clinical review of an under-recognised global challenge. Lancet Glob Health. 2021; 9(12): e1679–e1688.
24. Harries AD, Chakaya JM, Kumar AMV, Satyanarayana S, Lin Y, Zachariah R. Post-tuberculosis lung disease: a neglected area of research and policy. Int J Tuberc Lung Dis. 2016; 20(9):1142–4.
25. Gupte AN, Paradkar M, Selvaraju S, Mave V, Gupte N, Shivakumar SVBY, et al. Assessment of lung function in patients with post- tuberculosis sequelae. Int J Tuberc Lung Dis. 2019; 23(7):718–25.
26. Byrne AL, Marais BJ, Mitnick CD, Lecca L, Marks GB. Tuberculosis and chronic respiratory disease: a systematic review. Int J Infect Dis. 2015; 32:138–46.
27. Migliori GB, Nardell E, Yedilbayev A, D’Ambrosio L, Centis R, Tadolini M, et al. Reducing tuberculosis transmission: a consensus document. Int J Tuberc Lung Dis. 2019; 23(2):131–40.
28. Meghji J, Lesosky M, Joekes E, Banda P, Rylance J, Gordon S, et al. Patient outcomes associated with post-tuberculosis lung damage in Malawi: a prospective cohort study. Thorax. 2020; 75(3):269–78.
29. Byrne AL, Marais BJ, Mitnick CD, Lecca L, Marks GB. Tuberculosis and chronic respiratory disease: a systematic review. Int J Infect Dis. 2015; 32:138–46.
30. Harries AD, Ade S, Burney P, Hoa NB, Schluger NW, Williams BG. Successfully treated but not fit for purpose: paying attention to chronic lung impairment after TB treatment. Int J Tuberc Lung Dis. 2019; 23(7):820–2.
31. Migliori GB, Marx FM, Ambrosino N, Zampogna E, Schaaf HS, van der Zalm MM, et al. Clinical standards for the assessment, management, and rehabilitation of post-TB lung disease. Eur Respir J. 2021;57(4):2100255.
32. Allwood BW, Byrne A, Meghji J, Rachow A, van der Zalm MM, Schoch OD, et al. Post-TB lung disease: approaches to improve management in low- and middle-income countries. Int J Tuberc Lung Dis. 2021; 25(11): 891–901.
33. Martínez L, Cords O, Horsburgh CR Jr, Andrews JR. The risk of tuberculosis in children after close exposure: a systematic review and individual-participant meta-analysis. Lancet. 2020; 395(10228):973–84.
34. Migliori GB, Marx FM, Ambrosino N, Zampogna E, Schaaf HS, van der Zalm MM, et al. Clinical standards for the assessment, management, and rehabilitation of post-TB lung disease. Eur Respir J. 2021; 57(4):2100255.
35. Silva DR, Visca D, Connell DW, Alffenaar JW, Bonnett LJ, Fox GJ, et al. Long-term sequelae of pulmonary tuberculosis: a systematic review and meta-analysis. Eur Respir J. 2018;52(6):1800939.
36. Jones R, Kirenga B, Katagira W, Singh S, van Zyl Smit R, Nikolayevskyy V, et al. Post-tuberculosis lung disease: A global perspective on the need for care and rehabilitation. Int J Tuberc Lung Dis. 2021;25(9):731–42.
1. Osman M, van Schalkwyk C, Naidoo P, Seddon JA, Dunbar R, Dlamini SS, et al. Mortality during tuberculosis treatment in South Africa using an 8-year analysis of the national tuberculosis treatment register. Sci Rep. 2021;11(1):16427. doi:10.1038/s41598-021-95871-x
2. Fondo Colombiano de Enfermedades de Alto Costo. Situación del VIH en Colombia 2023. Bogotá: Cuenta de Alto Costo; 2024. Disponible en: https://cuentadealtocosto.org/site/publicaciones/
3. Odone A, Amadasi S, White RG, Cohen T, Grant AD, Houben RMGJ. The impact of antiretroviral therapy on mortality in HIV-positive people during tuberculosis treatment: a systematic review and meta-analysis. PLoS One. 2014;9(11): e112017. doi:10.1371/journal. pone.0112017
4. Ministerio de Salud y Protección Social. Resolución No. 227 de 2020. Por la cual se actualiza el protocolo de manejo de tuberculosis en Colombia. Bogotá: MinSalud; 2020.
5. Burtle D, Marsh S, Matin N. Update on the management of patients with HIV infection in anaesthesia and critical care. BJA Educ. 2023;23(7):264–72. doi:10.1016/j.bjae.2023.03.007
6. Gaviria SP, Zapata N, Villa P, Agudelo CA, Molina FJ, González MA, et al. HIV/AIDS infection in critical care: epidemiological profile and risk factors for mortality in a Colombian cohort. J Infect Dev Ctries. 2023;17(1):102–110. doi:10.3855/jidc.17100
7. Bell LCK, Noursadeghi M. Pathogenesis of HIV-1 and Mycobacterium tuberculosis co-infection. Nat Rev Microbiol. 2018;16(2):80–90. doi:10.1038/nrmicro.2017.128
8. Sterling TR, Pham PA, Chaisson RE. HIV infection-related tuberculosis: Clinical manifestations and treatment. Clin Infect Dis. 2010;50 Suppl 3: S223–30. doi:10.1086/651495
9. de Resende NH, de Miranda SS, Ceccato MDGB, Reis AMM, Haddad JPA, da Silva DI, et al. Assessment of factors associated with potential drug-drug interactions in patients with tuberculosis and HIV/AIDS. Rev Soc Bras Med Trop. 2021;54: e00742020. doi:10.1590/0037-8682-0742-2020
10. Cevaal PM, Bekker LG, Hermans S. TB-IRIS pathogenesis and new strategies for intervention: insights from related inflammatory disorders. Tuberculosis (Edinb). 2019;118:101858. doi:10.1016/j. tube.2019.101858
11. Abay SM, Deribe K, Reda AA, Biadgilign S, Datiko D, Assefa T, et al. The effect of early initiation of antiretroviral therapy in TB/HIV-coinfected patients: a systematic review and meta- analysis. J Int Assoc Provid AIDS Care. 2015;14(6):560–70. doi:10.1177/2325957414567687
12. Li L, Li J, Chai C, Liu T, Li P, Qu M, et al. Association of CD4 T cell count and optimal timing of antiretroviral therapy initiation with immune reconstitution inflammatory syndrome and all-cause mortality for HIV-infected adults with newly diagnosed pulmonary tuberculosis: a systematic review and meta-analysis. Int J Clin Exp Pathol. 2021;14(2):265–77. Disponible en: http://www.ijcep.com/ files/ijcep0122456.pdf
13. Abay SM, Deribe K, Reda AA, Biadgilign S, Datiko D, Assefa T, et al. The effect of early initiation of antiretroviral therapy in TB/HIV-coinfected patients: a systematic review and meta- analysis. J Int Assoc Provid AIDS Care. 2015;14(6):560–70. doi:10.1177/2325957414567687
14. Naidoo K, Yende-Zuma N, Padayatchi N, Naidoo K, Jithoo N, Nair G, et al. The immune reconstitution inflammatory syndrome after antiretroviral therapy initiation in patients with tuberculosis: findings from the SAPiT trial. Ann Intern Med. 2012;157(5):313–24. doi:10.7326/0003-4819-157-5-201209040-00004
15. Yan S, Chen L, Wu W, Fu Z, Zhang H, Li Z, et al. Early versus delayed antiretroviral therapy for HIV and tuberculosis co-infected patients: a systematic review and meta-analysis of randomized controlled trials. PLoS One. 2015;10(5): e0127645. doi:10.1371/ journal.pone.0127645 Capítulo 3. La TB y la Enfermedad post-TB, consideraciones para su manejo en UCI
Chaudhry D, Tyagi D. Tuberculosis in Intensive Care Unit. Indian J Crit Care Med. 2021;25(Suppl 2): S150. doi:10.5005/JP- JOURNALS-10071-23872
World Health Organization. Global Tuberculosis Report 2024. Geneva: WHO; 2024.
Otu A, Hashmi M, Mukhtar AM, et al. The critically ill patient with tuberculosis in intensive care: Clinical presentations, management, and infection control. J Crit Care. 2018; 45:184-196.
Galvin J, Tiberi S, Akkerman O, et al. Pulmonary tuberculosis in intensive care settings, with a focus on the use of severity scores: a multinational collaborative systematic review. Pulmonology. 2022;28(4):297-309.
Chacko B, Chaudhry D, Peter JV, et al. ISCCM Position Statement on the Approach to and Management of Critically Ill Patients with Tuberculosis. Indian J Crit Care Med. 2024;28(Suppl 2): S67.
Tiberi S, Torrico MM, Rahman A, et al. Managing severe tuberculosis and its sequelae: from intensive care to surgery and rehabilitation. J Bras Pneumol. 2019;45(2): e20180324.
Silva DR, Menegotto DM, Schulz LF, et al. Mortality among patients with tuberculosis requiring intensive care: A retrospective cohort study. BMC Infect Dis. 2010; 10:54.
Pecego AC, Amancio RT, Ribeiro C, et al. Six-month survival of critically ill patients with HIV-related disease and tuberculosis: A retrospective study. BMC Infect Dis. 2016; 16:1-9.
Muthu V, Agarwal R, Dhooria S, et al. Outcome of Critically Ill Subjects with Tuberculosis: Systematic Review and Meta-Analysis. Respir Care. 2018;63(12):1541-1554.
Loh WJ, Yu Y, Loo CM, et al. Factors associated with mortality among patients with active pulmonary tuberculosis requiring intensive care. Singapore Med J. 2017;58(11):656-659.
Erbes R, Oettel K, Raffenberg M, et al. Characteristics and Outcomes of Patients with Active Pulmonary Tuberculosis Requiring Intensive Care Eur Respir J. 2006;27(6):1223-1228.
Cui K, Mao Y, Feng S, et al. Association Between Age and the 28-Day All-Cause Mortality in Tuberculosis Complicated by Sepsis in ICU Patients: A Retrospective Cohort Study. Infect Drug Resist. 2024; 17:1879.
Thomas L, Chacko B, Jupudi S, et al. Clinical Profile and Outcome of Critically Ill Patients with Tuberculosis. Indian J Crit Care Med. 2021;25(1):21.
Freercks R, Gigi N, Aylward R, et al. Scope and mortality of adult medical ICU patients in an Eastern Cape tertiary hospital. South Afr J Crit Care. 2022;38(3):10.
Tatar D, Senol G, Kirakli C, et al. Contributing factors to mortality rates of pulmonary tuberculosis in intensive care units. J Chin Med Assoc. 2018;81(7):605-610.
Wang JL, Yin QY, Han C, et al. Risk factors for death in tuberculosis patients requiring ICU care. Epidemiol Infect. 2021; 149: e22.
Huang XQ, Pan L, Pan XH, et al. The Correlation between 25-Hydroxyvitamin D3 and the Severity and Short-Term Prognosis of Pulmonary Tuberculosis. Clin Lab. 2022;68(3):559-564.
Kim WY, Kim MH, Jo EJ, et al. Predicting Mortality in Patients with Tuberculous Destroyed Lung Receiving Mechanical Ventilation. Tuberc Respir Dis. 2018;81(3):247.
Cui K, Mao Y, Feng S, et al. Development and Validation of a Risk Mortality Prediction Model for Patients with Pulmonary Tuberculosis Complicated by Severe Community-Acquired Pneumonia in the Intensive Care Unit. Infect Drug Resist. 2024; 17:3113.
Vesteinsdottir E, Myrdal G, Sverrisson KO, Skarphedinsdottir SJ, Gudlaugsson O, Karason S. ARDS from miliary tuberculosis successfully treated with ECMO. Respir Med Case Rep. 2019; 26:165. doi:10.1016/J.RMCR.2019.01.005
Agarwal R, Gupta D, Aggarwal AN, Behera D, Jindal SK. Experience with ARDS caused by tuberculosis in a respiratory intensive care unit. Intensive Care Med. 2005;31(9):1284. doi:10.1007/S00134- 005-2721-2
Erdem H, Ozturk-Engin D, Tireli H, et al. Hamsi scoring in the prediction of unfavorable outcomes from tuberculous meningitis: results of Haydarpasa-II study. J Neurol. 2015;262(4):890-898. doi:10.1007/ S00415-015-7651-5
Kethireddy S, Light RB, Mirzanejad Y, et al. Mycobacterium tuberculosis septic shock. Chest. 2013;144(2):474-482. doi:10.1378/chest.12-1286
Angoulvant D, Mohammedi I, Duperret S, Bouletreau P. Septic shock caused by Mycobacterium tuberculosis in a non-HIV patient [3]. Intensive Care Med. 1999;25(2):238. doi:10.1007/S001340050825/ METRICS
Ferrand RA, Herman J, Elgalib A, Cartledge J, Miller RF. Septic shock and multi-organ failure in HIV infection-’sepsis tuberculosa gravissima’. Int J STD AIDS. 2006;17(8):562-564. doi:10.1258/095646206778145578
Agarwal R, Gupta D, Handa A, Aggarwal AN. Noninvasive ventilation in ARDS caused by Mycobacterium tuberculosis: Report of three cases and review of literature [1]. Intensive Care Med. 2005;31(12):1723-1724. doi:10.1007/S00134-005-2823-X/TABLES/1
Esquinas AM, Egbert Pravinkumar S, Scala R, et al. Noninvasive mechanical ventilation in high-risk pulmonary infections: a clinical review. European Respiratory Review. 2014;23(134):427. doi:10.1183/09059180.00009413
Idris R, Zielbauer AS, Koepsell J, Kloka J, Wetzstein N. Extracorporeal membrane oxygenation (ECMO) in patients with tuberculosis: systematic review and meta-analysis of 43 cases. BMC Pulm Med. 2024;24(1):1-10. doi:10.1186/S12890-023-02715-X/TABLES/4
Charya A V., Holden VK, Pickering EM. Management of life-threatening hemoptysis in the ICU. J Thorac Dis. 2021;13(8):5139-5158. doi:10.21037/JTD-19-3991
Lin C, Chen Y, Cai D, et al. The efficacy and safety of combined therapy with endobronchial tamponade and bronchial artery embolization for massive hemoptysis. BMC Pulm Med. 2024;24(1):1-9. doi:10.1186/ S12890-024-03116-4/FIGURES/5
Hsiao EI, Kirsch CM, Kagawa FT, Wehner JH, Jensen WA, Baxter RB. Utility of fiberoptic bronchoscopy before bronchial artery embolization for massive hemoptysis. American Journal of Roentgenology. 2001;177(4):861-867. doi:10.2214/ AJR.177.4.1770861/ASSET/IMAGES/10_AA1377_07.JPEG
Tao Y, Li J, Su R, Zhou M, Zhu H, Sun Z. The efficacy, safety, and related factors of bronchial artery embolization for hemoptysis: a systematic review and meta-analysis with subgroup analysis. Cardiovasc Diagn Ther. 2024;14(5):859-877. doi:10.21037/CDT-24- 157/COIF
Zahar JR, Azoulay E, Klement E, et al. Delayed treatment contributes to mortality in ICU patients with severe active pulmonary tuberculosis and acute respiratory failure. Intensive Care Med. 2001;27(3):513- 520. doi:10.1007/S001340000849/METRICS
Koegelenberg CFN, Nortje A, Lalla U, et al. The pharmacokinetics of enteral antituberculosis drugs in patients requiring intensive care. S Afr Med J. 2013;103(6):394-398. doi:10.7196/SAMJ.6344
Hernández-Cárdenas C, Lugo-Goytia G. Pharmacokinetics of antituberculosis drugs in critically ill patients with tuberculosis and acute respiratory failure. Crit Care. 2014;18(Suppl 1):P354. doi:10.1186/CC13544
Anton C, Lemos CX, Machado FD, Bernardi RM, Freitas AA, Silva DR. Tuberculosis in the intensive care unit: alternative treatment regimens and association with mortality. Tropical Medicine & International Health. 2021;26(1):111-114. doi:10.1111/TMI.13511
Ruslami R, Ganiem AR, Dian S, et al. Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open- label, randomised controlled phase 2 trial. Lancet Infect Dis. 2013;13(1):27-35. doi:10.1016/S1473-3099(12)70264-5
Boeree MJ, Heinrich N, Aarnoutse R, et al. High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi- arm, multi-stage randomised controlled trial. Lancet Infect Dis. 2017;17(1):39-49. doi:10.1016/S1473-3099(16)30274-2
Jothimani D, Sachan D, Saha S, Kalyamoorthy I, Rela M. 4. Role of therapeutic plasma exchange (TPE) in patients with drug- induced liver injury. J Clin Exp Hepatol. 2018 ;8:S83. doi:10.1016/j. jceh.2018.06.425
Prasad K, Singh MB, Ryan H. Corticosteroids for managing tuberculous meningitis. Cochrane Database of Systematic Reviews. 2016;2016(4). doi:10.1002/14651858.CD002244.PUB4/MEDIA/ CDSR/CD002244/IMAGE_N/NCD002244-CMP-004-01.PNG
1. World Health Organization. Global tuberculosis report. Geneva, Switzerland: WHO; 2023. https://www.who.int/es/news-room/fact- sheets/detail/tuberculosis.
2. Tobín MJ. Ventilación mecánica. 2. ed. Nueva York: McGraw-Hill; 2013.
3. Kim S, Kim H, Kim WJ, et al. Mortality and predictors in pulmonary tuberculosis with respiratory failure requiring mechanical ventilation. Int J Tuberc Lung Dis. 2016;20(5):524–9.
4. Karakas A, Turhan V, Esquinas AM. Reasons for high mortality rates in patients with pulmonary tuberculosis needing mechanical ventilation. Int J Tuberc Lung Dis. 2016;20(10):1416–9.
5. Agarwal R, Gupta D, Aggarwal AN, et al. Experience with ARDS caused by tuberculosis in a respiratory intensive care unit. Intensive Care Med. 2005; 31:1284–7.
6. Alsayed SSR, Gunosewoyo H. Tuberculosis: Pathogenesis, Current Treatment Regimens and New Drug Targets. Int. J. Mol. Sci. 2023; 24(6): 5202.
7. Aso H, Kondoh Y, Taniguchi H, Kimura T, Nishiyama O, Kato K, et al. Noninvasive ventilation in patients with acute exacerbation of pulmonary tuberculosis sequelae. Intern Med. 2010;49(19):2077– 83.
8. Muñoz J, Cedeño JA, Castañeda GF, Visedo LC. Personalized ventilation adjustment in ARDS: A systematic review and meta- analysis of image, driving pressure, transpulmonary pressure, and mechanical power. Heart Lung. 2024; 68:305–15.
9. Gong Y, Ponnapalli A, Hafeez K, Soubani AO. Noninvasive ventilation for respiratory failure: When does it work and when it does not? Am J Med Sci. 2025;369(5):547–55.
10. Davidson J, Chesen B, Kumar S, Shayowitz DJ. Hospital Practices for Respiratory Isolation for Patients with Suspected Tuberculosis and Potential Application of Prediction Models. Cureus. 2022;14(12).
11. Hashemian SM, Khoundabi B, Bahrami A, Jamaati H, Varahram M, Saljoughi L, et al. Optimal Positive End-expiratory Pressure Levels in Tuberculosis-associated Acute Respiratory Distress Syndrome. Int J Mycobacteriol. 2024;13(3):247–51.
12. Muthu V, Dhooria S, Aggarwal AN, Behera D, Sehgal IS, Agarwal R. Acute Respiratory Distress Syndrome Due To Tuberculosis in a Respiratory ICU Over 16 years. Crit Care Med. 2017;45(10): e1087– 90.
13. Hamahata N, Pinsky MR. Heart-Lung Interactions. Semin Respir Crit Care Med. 2023;44(5):650–60.
14. Northam KA, Phillips KM. Sedation in the ICU. NEJM Evid. 2024;3(11).
15. Kyo M, Shimatani T, Hosokawa K, Taito S, Kataoka Y, Ohshimo S, et al. Patient-ventilator asynchrony, impact on clinical outcomes and effectiveness of interventions: a systematic review and meta- analysis. J Intensive Care. 2021;9(1):50.
1. World Health Organization. Global tuberculosis report 2021. Geneva: WHO; 2021.
2. García-Rivero R, Ramírez-López J, Sánchez-Ortega A. Trayectorias de atención en tuberculosis: interacciones entre cultura, enfermedad y atención en salud. Rev Fac Nac Salud Pública. 2019;37(3):384–94.
3. Varela B, Sánchez F, Rincón C. Factores sociales asociados a la tuberculosis: una revisión narrativa. Rev Cienc Salud. 2023;21(2):121–36.
4. Perlaza R, Cardona S, Roldán J. Determinantes sociales y abandono del tratamiento en tuberculosis pulmonar. Rev Salud Pública. 2023;25(1):29–39.
5. Bonilla-Asalde C, Rivera-Lozada O, Rivera-Lozada B. Estigma y tuberculosis: una barrera para la adherencia terapéutica. Rev Peru Med Exp Salud Publica. 2021;38(4):618–23.
6. Upegui-Arango LD, Orozco L. Perspectivas de adherencia terapéutica en TB: desafíos y oportunidades. Biomédica. 2019;39(Supl.1):90–100.
7. Plata-Casas JP. Tuberculosis multirresistente: retos actuales para el sistema de salud. Rev Gerenc Polit Salud. 2015;14(29):36–47.
8. Li J. Addressing challenges in TB treatment adherence: a review. Int J Tuberc Lung Dis. 2021;25(4):299–310.
9. Antolinez-Figueroa D, Castañeda E, Marín MJ. Significados sociales del diagnóstico de tuberculosis en Colombia. Salud Colect. ,2022;18: e3996.
10. Instituto Nacional de Salud. Informe de evento tuberculosis 2021. Bogotá: INS; 2023.
11. Castro M, Camarena A, Fernández M. Barreras sociales en el tratamiento de la tuberculosis: un enfoque desde los determinantes sociales. Rev. Salud Pública (Bogotá). 2020;22(3):e220304.
12. Munro SA, Lewin SA, Smith HJ, Engel ME, Fretheim A, Volmink J. Patient adherence to tuberculosis treatment: a systematic review of qualitative research. PLoS Med. 2007;4(7): e238.
13. Salaverry O. Antropología médica: una mirada crítica desde la salud. Rev Peru Med Exp Salud Publica. 2017;34(2):339–45.
14. Cornejo M, Mendoza F, Rojas C. Historia de vida y construcción de sentido: reflexiones metodológicas para la investigación cualitativa. Psykhe (Santiago). 2008;17(2):29–39.
1. Brown J, Capocci S, Smith C, Morris S, Abubakar I, Lipman M. Health status and quality of life in tuberculosis. Int J Infect Dis. 2015; 32:68– 75. Available from: http://dx.doi.org/10.1016/j.ijid.2014.12.045
2. World Health Organization. WHOQOL: Measuring quality of life. Geneva: WHO; 1997.
3. Fernández-López JA, Fernández-Fidalgo M, Cieza A. Los conceptos de calidad de vida, salud y bienestar son analizados desde la perspectiva de la clasificación internacional del funcionamiento (CIF). Rev. Esp. Salud Pública. 2010;84(2):169–84.
4. Samuel R, Natesan S, Bangera MK. Quality of life and associated factors in pulmonary tuberculosis patients. Indian J Tuberc. 2023;70(2):214–21. Available from: https://doi.org/10.1016/j. ijtb.2022.05.005
5. Wang H, Gu J, Zhang L, Song Y. Assessing the quality of life in patients with drug-resistant tuberculosis: a cross-sectional study. BMC Pulm Med. 2024;24(1):1–11.
6. Aggarwal AN. Quality of life with tuberculosis. J Clin Tuberc Other Mycobact Dis. 2019; 17:100121. Available from: https://doi. org/10.1016/j.jctube.2019.100121
7. Bauer M, Leavens A, Schwartzman K. A systematic review and meta- analysis of the impact of tuberculosis on health-related quality of life. Qual Life Res. 2013;22(8):2213–35.
8. Lutfian L, Azizah A, Wardika IJ, Wildana F, Maulana S, Wartakusumah R. The role of family support in medication adherence and quality of life among tuberculosis patients: A scoping review. Japan J Nurs Sci. 2025;22(1):1–11.
9. Alene KA, Clements ACA, McBryde ES, Jaramillo E, Lönnroth K, Shaweno D, et al. Mental health disorders, social stressors, and health-related quality of life in patients with multidrug-resistant tuberculosis: A systematic review and meta-analysis. J Infect. 2018;77(5):357–67. Available from: https://doi.org/10.1016/j. jinf.2018.07.007
10. Ramachandran R, Dumitrescu A, Baiceanu D, Popa C, Dragomir A, Mahler B, et al. Impact of drug-resistant tuberculosis on socio- economic status, quality of life, and psychological well-being of patients in Bucharest, Romania: a prospective cohort study. J Heal Popul Nutr. 2024;43(1).
11. Meghji J, Gregorius S, Madan J, Chitimbe F, Thomson R, Rylance J, et al. The long-term effect of pulmonary tuberculosis on income and employment in a low-income, urban setting. Thorax. 2021;76(4):387–95.
12. Abdulelah J, Azhar S, Sulaiman S, Hassali MA, et al. Development and psychometric properties of a tuberculosis-specific multidimensional health-related quality-of-life measure for patients with pulmonary tuberculosis. Value Health Reg Issues. 2015; 6:53–9. Available from: http://dx.doi.org/10.1016/j.vhri.2015.03.006
13. Vernon A, Fielding K, Savic R, Dodd L, Nahid P. The importance of adherence in tuberculosis treatment clinical trials and its relevance in explanatory and pragmatic trials. PLoS Med. 2019;16(12): e1002884.
1. Allwood BW, van der Zalm MM, Amaral AFS, Byrne A, Datta S, Egere U, et al. Post-tuberculosis lung health: perspectives from the First International Symposium. Int J Tuberc Lung Dis. 2020;24(8):820– 8.
2. Meghji J, Gregorius S, Madan J, Chitimbe F, Thomson R, Rylance J, et al. The long-term effect of pulmonary tuberculosis on income and employment in a low-income, urban setting. Thorax. 2021; 76(4):387–95.
3. World Health Organization. WHO consolidated guidelines on tuberculosis. Module 5: Management of tuberculosis in children and adolescents. Geneva: WHO; 2022.
4. Byrne AL, Marais BJ, Mitnick CD, Lecca L, Marks GB. Tuberculosis and chronic respiratory disease: a systematic review. Int J Infect Dis. 2015; 32:138–46.
5. Ramos LM, Sulmonett N, Ferreira CS, Henriques JF, Oliveira JR, da Costa CH. Functional profile of patients with tuberculosis sequelae in a university hospital. J Bras Pneumol. 2006;32(1):43–7.
6. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six- minute walk test. Am J Respir Crit Care Med. 2002;166(1):111–
7. Hnizdo E, Singh T, Churchyard G. Chronic pulmonary function impairment caused by initial and recurrent pulmonary tuberculosis following treatment. Thorax. 2000; 55(1):32–8.
8. Gupte AN, Paradkar M, Selvaraju S, et al. Assessment of post- tuberculosis lung impairment using spirometry and 6-minute walk test: a prospective cohort study. BMC Pulm Med. 2021;21(1):234.
9. Chaves Torres NM, Quijano Rodríguez JJ, Porras Andrade MJ, Arrieta JH. The impact of tuberculosis on health-related quality of life: a follow-up study. Arch Bronconeumol. 2022;58(5):386–92.
10. Meghji J, Mortimer K, Agusti A, et al. Improving lung health in low-income and middle-income countries: from challenges to solutions. Lancet. 2021;397(10277):928–40.
11. Allwood BW, Byrne A, Meghji J, et al. Post-tuberculosis lung disease: clinical review of an under-recognised global challenge. Respiration. 2021;100(8):751–63.
12. de Albuquerque MFP, Campelo ARL, de Souza WV, et al. Post- tuberculosis pulmonary function impairment: a systematic review and meta-analysis. Chest. 2023;163(5):1120–34.
13. Holland AE, Spruit MA, Troosters T, et al. An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J. 2014;44(6):1428–46.
14. Tudor Car L, van Velthoven MH, Brusamento S, et al. Telehealth strategies for the delivery of pulmonary rehabilitation in chronic respiratory diseases: a systematic review and meta-analysis. NPJ Prim Care Respir Med. 2022;32(1):5.
15. Visca D, Zampogna E, Sotgiu G, et al. Pulmonary rehabilitation is effective in patients with tuberculosis pulmonary sequelae. Eur Respir J. 2021;57(3):2002566.
16. Ahmed AE, Al-Hajjaj MS, Al-Harbi AS. Pulmonary function and 6-minute walk test in patients with post-tuberculosis pulmonary impairment. Saudi Med J. 2020;41(9):976–81.
17. Organización Panamericana de la Salud (OPS). Evaluación del seguimiento post-tratamiento de tuberculosis pulmonar en América Latina. Informe técnico 2023.
18. Amaral AF, Coton S, Kato B, Tan WC, Studnicka M, Janson C, et al. Tuberculosis associates with both airflow obstruction and low lung function: BOLD results. Eur Respir J. 2015;46(4):1104–12. doi:10.1183/13993003.02325-2014
19. Meghji J, Lesosky M, Joekes E, Banda P, Rylance J, Gordon S, et al. Patient outcomes associated with post-tuberculosis lung damage in Malawi: a prospective cohort study. Thorax. 2020;75(3):269– 78. doi:10.1136/thoraxjnl-2019-213808
20. Allwood BW, van der Zalm MM, Amaral AFS, Byrne A, Datta S, Egere U, et al. Post-tuberculosis lung health: perspectives from the First International Symposium. Int J Tuberc Lung Dis. 2020;24(8):820– 8. doi:10.5588/ijtld.20.0147
21. Migliori GB, Marx FM, Ambrosino N, Zampogna E, Visca D, Centis R. Clinical standards for the assessment, management and rehabilitation of post-TB lung disease. Int J Tuberc Lung Dis. 2021;25(10):797–813. doi:10.5588/ijtld.21.0427
22. Meghji J, Gregorius S, Madan J, Chitimbe F, Thomson R, Rylance J, et al. The long-term effect of pulmonary tuberculosis on income and employment in a low-income, urban setting. Thorax. 2021;76(4):387–95. doi:10.1136/thoraxjnl-2020-215338
23. Migliori GB, Marx FM, Ambrosino N, Zampogna E, Visca D, Centis R. Clinical standards for the assessment, management and rehabilitation of post-TB lung disease. Int J Tuberc Lung Dis. 2021;25(10):797–813. doi:10.5588/ijtld.21.0427
24. World Health Organization. WHO consolidated guidelines on tuberculosis. Module 5: management of tuberculosis in children and adolescents. Geneva: WHO; 2022. Available from: https:// www.who.int/publications/i/item/9789240060472
1. Allwood BW, Byrne A, Meghji J, et al. Post-tuberculosis lung disease: clinical review of an under-recognised global challenge. Lancet Glob Health. 2021;9(12): e1679–e1688.
2. Meghji J, Lesosky M, Joekes E, et al. Patient outcomes associated with post-tuberculosis lung damage in Malawi: a prospective cohort study. Thorax. 2020;75(3):269–78.
3. Chaudhry D, Tyagi D. Tuberculosis in Intensive Care Unit. Indian J Crit Care Med. 2021;25(Suppl 2): S150.
4. Mohr-Holland E, et al. Quality of life and functional status in TB survivors: A neglected dimension of post-TB care. Int J Tuberc Lung Dis. 2022;26(1):15–23.
5. Seneviratne S, et al. Validation of FACIT-TB for assessing quality of life in post-TB patients. Appl Res Qual Life. 2022;17(2):579–92.
dc.rights.license.none.fl_str_mv Atribución-NoComercial-SinDerivadas 4.0 Internacional (CC BY-NC-ND 4.0)
dc.rights.uri.none.fl_str_mv https://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rights.coar.none.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.rights.accessrights.none.fl_str_mv info:eu-repo/semantics/openAccess
rights_invalid_str_mv Atribución-NoComercial-SinDerivadas 4.0 Internacional (CC BY-NC-ND 4.0)
https://creativecommons.org/licenses/by-nc-nd/4.0/
http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv openAccess
dc.format.extent.none.fl_str_mv 190 páginas
dc.format.mimetype.none.fl_str_mv application/pdf
dc.coverage.region.none.fl_str_mv Pereira, Risaralda, Colombia
dc.publisher.none.fl_str_mv Universidad Tecnológica de Pereira
dc.publisher.place.none.fl_str_mv Pereira
publisher.none.fl_str_mv Universidad Tecnológica de Pereira
institution Universidad Tecnológica de Pereira
bitstream.url.fl_str_mv https://repositorio.utp.edu.co/bitstreams/7bc01e8e-bc17-4e94-b521-c8b6ae93eb22/download
https://repositorio.utp.edu.co/bitstreams/90f427ab-7b71-4c2a-8ddc-ff52f584ce5d/download
https://repositorio.utp.edu.co/bitstreams/5b0e47e6-eb38-4dc3-ae03-939c25b7bf0f/download
https://repositorio.utp.edu.co/bitstreams/ce1d3796-3fa4-4fda-95d3-a7740df40ee0/download
https://repositorio.utp.edu.co/bitstreams/66e69135-ef5b-4e1a-80ab-4ad7b432a8e3/download
bitstream.checksum.fl_str_mv e7bdd95f80e6d2baa0469f17639b634c
73a5432e0b76442b22b026844140d683
a76beb2e69e5679416852906655cfca6
8bde279550b8a5ed2ef245a0fedac1de
48d49739279e299492712323a337d915
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositorio de la Universidad Tecnológica de Pereira
repository.mail.fl_str_mv bdigital@metabiblioteca.com
_version_ 1851051536301424640
spelling Atribución-NoComercial-SinDerivadas 4.0 Internacional (CC BY-NC-ND 4.0)Manifiesto (Manifestamos) en este documento la voluntad de autorizar a la Biblioteca Jorge Roa Martínez de la Universidad Tecnológica de Pereira la publicación en el Repositorio institucional (http://biblioteca.utp.edu.co), la versión electrónica de la OBRA titulada: La Universidad Tecnológica de Pereira, entidad académica sin ánimo de lucro, queda por lo tanto facultada para ejercer plenamente la autorización anteriormente descrita en su actividad ordinaria de investigación, docencia y publicación. La autorización otorgada se ajusta a lo que establece la Ley 23 de 1982. Con todo, en mi (nuestra) condición de autor (es) me (nos) reservo (reservamos) los derechos morales de la OBRA antes citada con arreglo al artículo 30 de la Ley 23 de 1982. En concordancia suscribo (suscribimos) este documento en el momento mismo que hago (hacemos) entrega de mi (nuestra) OBRA a la Biblioteca “Jorge Roa Martínez” de la Universidad Tecnológica de Pereira. Manifiesto (manifestamos) que la OBRA objeto de la presente autorizaciónhttps://creativecommons.org/licenses/by-nc-nd/4.0/http://purl.org/coar/access_right/c_abf2info:eu-repo/semantics/openAccessGiraldo Montoya, Angela MaríaGarcía Castro, GiovanniGarcía Giraldo, Laura SofiaSierra Garzón, Luisa FernandaFernández Cabrera, Gloria StefanyMartínez, José WilliamOrdoñez Díaz, Karen MelissaGiraldo Diaconeasa, AdriánGiraldo Gómez, Jenifer2025-11-10T20:00:31Z2025-11-10T20:00:31Z2025Giraldo Montoya, A, García Castro, G, García Giraldo, L, Sierra Garzón, L, Fernández Cabrera, G, Martínez, J, Ordoñez Díaz, K, Giraldo Diaconeasa, A y Giraldo Gómez, J. (2025). Enfermedad pulmonar post-tuberculosis (PTLD): perspectivas clínicas, funcionales y sociales. Universidad Tecnológica de Pereira. Disponible en: https://hdl.handle.net/11059/16449https://hdl.handle.net/11059/16449978-628-501-066-8https://doi.org/10.22517/9786285010668Universidad Tecnológica de PereiraRepositorio Universidad Tecnológica de Pereirahttps://repositorio.utp.edu.co/home: tablas, figurasEl libro “Enfermedad Pulmonar Post-Tuberculosis (PTLD): Perspectivas clínicas, funcionales y sociales” es una obra académica interdisciplinaria desarrollada en la Facultad de Ciencias de la Salud de la Universidad Tecnológica de Pereira, en el marco de un proyecto financiado por la Vicerrectoría de Investigaciones, Innovación y Extensión. Su propósito es abordar integralmente la enfermedad pulmonar post-tuberculosis (PTLD), un síndrome emergente que afecta a personas curadas de tuberculosis, provocando secuelas estructurales, funcionales y sintomáticas de largo plazo. El texto reúne perspectivas clínicas, fisiopatológicas, epidemiológicas, sociales y funcionales, estructuradas en tres grandes secciones: 1. Perspectivas clínicas y fisiopatológicas: analiza la fisiopatología de la tuberculosis y la PTLD, su relación con el VIH, las implicaciones en unidades de cuidado intensivo y el manejo de la ventilación mecánica en pacientes con secuelas respiratorias severas. 2. Dimensión social y simbólica: presenta resultados de investigación sobre trayectorias de cuidado, adherencia terapéutica y determinantes socioculturales en pacientes con tuberculosis. 3. Función pulmonar y calidad de vida: incluye estudios sobre espirometría, caminata de seis minutos, escalas de calidad de vida (como la FACIT-TB) y análisis de impacto clínico y funcional.The book “Post-Tuberculosis Lung Disease (PTLD): Clinical, Functional and Social Perspectives”is an interdisciplinary academic work developed by the Faculty of Health Sciences at the Technological University of Pereira (UTP), within a research project funded by the Vice-Rectorate for Research, Innovation and Extension. Its main purpose is to address comprehensively the Post-Tuberculosis Lung Disease (PTLD)—an emerging condition that affects individuals who have been cured of tuberculosis but continue to experience persistent structural, functional, and symptomatic respiratory sequelae. The book integrates clinical, pathophysiological, epidemiological, social, and functional perspectives, organized into three major sections: 1. Clinical and Pathophysiological Perspectives: analyzes the pathophysiology of tuberculosis and PTLD, its interaction with HIV, critical care management in intensive care units, and mechanical ventilation strategies for patients with severe respiratory sequelae. 2. Social and Symbolic Dimensions: presents research findings on sociocultural factors, treatment adherence, and care trajectories among patients living with tuberculosis. Pulmonary Function and Quality of Life: includes studies on spirometry, six-minute walk tests, quality-of-life assessment using instruments such as the FACIT-TB scale, and evaluations of clinical and functional impact.Introducción -7 -- Referencias- 11 -- Sección I Perspectivas clínicas y fisiopatológicas de la tuberculosis y el daño pulmonar residual -- 15 Capítulo 1 Fisiopatología y manifestaciones clínicas de la tuberculosis y la PTLD -- 17 Referencias -- 29 Capítulo 2 Tuberculosis, VIH y enfermedad pulmonar post-tuberculosis -- 35 Referencias -- 44 Capítulo 3 La TB y la Enfermedad post-TB, consideraciones para su manejo en UCI -- 49 Referencias -- 64 Capítulo 4 Ventilación mecánica en pacientes con tuberculosis pulmonar -- 71 Referencias -- 82 Sección II Dimensión social, simbólica y vivencial de la enfermedad pulmonar post-TB, resultados de investigación -- 85 Capítulo 5 Factores socioculturales, trayectorias de cuidado y adherencia terapéutica en pacientes con tuberculosis -- 87 Referencias -- 111 Sección III Función pulmonar, calidad de vida y evaluación en PTLD, resultados de investigación -- 115 Capítulo 6 Calidad de vida en pacientes con PTLD: una dimensión subestimada del daño residual -- 117 Referencias -- 127 Capítulo 7 Evaluación funcional pulmonar: espirometría, caminata de 6 minutos y perfil clínico de pacientes con PTLD -- 131 Referencias -- 145 Capítulo 8 Conclusiones generales: hacia una comprensión integral de la PTLD -- 151 Referencias -- 158190 páginasapplication/pdfspaUniversidad Tecnológica de PereiraPereiraColección Trabajos de Investigación1. World Health Organization. Global tuberculosis report 2023. Geneva: WHO; 2023. Disponible en: https://www.who.int/publications/i/ item/97892400838512. Romanowski K, Baumann B, Basham CA, Khan FA, Fox GJ, Johnston JC. Long-term all-cause mortality in people treated for tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis. 2019;19(10):1129–37. doi:10.1016/S1473-3099(19)30309-33. Migliori GB, Centis R, D’Ambrosio L, Tiberi S, Zumla A. Multidrug- resistant tuberculosis and extensively drug-resistant tuberculosis. Eur Respir J. 2021;57(6):2100633. doi:10.1183/13993003.00633- 20214. Allwood BW, Byrne A, Meghji J, Rachow A, van der Zalm MM, Schoch OD, et al. Post-tuberculosis lung health: perspectives from the First International Symposium. Int J Tuberc Lung Dis. 2020;24(8):820–8. doi:10.5588/ijtld.20.00675. Byrne AL, Marais BJ, Mitnick CD, Lecca L, Marks GB. Chronic airflow obstruction after successful treatment of tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis. 2015;15(8):905–13. doi:10.1016/S1473-3099(15)00037-76. World Health Organization. Roadmap towards ending TB in children and adolescents. 2nd ed. Geneva: WHO; 2023.7. Dheda K, Ruhwald M, Theron G, Peter J, Yam WC. The WHO definition of post-tuberculosis lung disease: improving data for care, research, and policy. Lancet Respir Med. 2021;9(9):839–46. doi:10.1016/S2213-2600(21)00254-88. Meghji J, Simpson H, Squire SB, Mortimer K. The long-term effect of pulmonary tuberculosis on lung function: a systematic review and meta-analysis. Thorax. 2016;71(10):849–61. doi:10.1136/ thoraxjnl-2015-2074919. Mpagama SG, Kibiki GS, Ulenga N, Mbelele P, Lema LE, Semvua HH, et al. The prevalence and pattern of post-tuberculosis lung disease in patients who successfully completed TB treatment. BMC Pulm Med. 2025; 25:3549. doi:10.1186/s12890-025-03549-510. Allwood BW, van der Zalm MM, Meintjes G, Maartens G, Warren R, Dheda K, et al. Post-tuberculosis lung disease: addressing the policy gap. PLOS Glob Public Health. 2023;3(8): e0003560. doi:10.1371/journal.pgph.000356011. Seneviratne S, Rathnayake D, Wijesinghe A, de Silva S, Jayasuriya R. Validation of FACIT-TB for assessing quality of life in post-TB patients. Appl Res Qual Life. 2022;17(2):579–92. doi:10.1007/ s11482-021-09927-512. Bhattacharyya P, Datta D, Saha D, Paul R, Mitra DK. Tuberculosis- associated pulmonary hypertension: the revelation of a clinical observation. Lung India. 2016;33(2):135. doi:10.4103/0970- 2113.17743313. Shrestha A, Aryal S, Sharma S, Adhikari J. Artificial intelligence in tuberculosis imaging: current status and future directions. J Thorac Dis. 2023;15(2):423–35. doi:10.21037/jtd-22-91714. Migliori GB, Duarte R, Tiberi S, Zumla A. Tuberculosis: the new challenges. Eur Respir Rev. 2022;31(165):220063. doi:10.1183/16000617.0063-20221. World Health Organization. Global tuberculosis report 2021. Geneva: WHO; 2021.2. Meghji J, Lesosky M, Joekes E, Banda P, Rylance J, Gordon SB, et al. Patient outcomes associated with post-TB lung damage in Malawi: a prospective cohort study. Thorax. 2020; 75(3):269–78.3. Hnizdo E, Singh T, Churchyard G. Chronic pulmonary function impairment caused by initial and recurrent pulmonary tuberculosis following treatment. Thorax. 2000;55(1):32–8.4. Pasipanodya JG, Miller TL, Vecino M, Munguia G, Bae S, Drewyer G, et al. Pulmonary impairment after tuberculosis. Chest. 2007;131(6):1817–24.5. Allwood BW, Byrne A, Meghji J, Rachow A, van der Zalm MM, Schoch OD, et al. Post-tuberculosis lung disease: Clinical review of an under-recognised global challenge. Lancet Glob Health. 2021;9(12): e1670–8.6. van Kampen SC, Wanner A, Edwards M, Harries AD, Kirenga BJ, Chakaya JM, et al. International research and guidelines on post- tuberculosis chronic lung disorders: A systematic scoping review. BMJ Glob Health. 2018;3(4): e000745.7. Datta S, Evans CA. Post-tuberculosis lung disease: the next global epidemic. Lancet Glob Health. 2019;7(12): e1678–9.8. Liu CH, Liu H, Ge B. Innate immunity in tuberculosis: host defense vs pathogen evasion. Cell Mol Immunol. 2017;14(12):963–75.9. Ramakrishnan L. Revisiting the role of the granuloma in tuberculosis. Nat Rev Immunol. 2012; 12(5):352–66.10. Saunders BM, Britton WJ. Life and death in the granuloma: immunopathology of tuberculosis. Immunol Cell Biol. 2007; 85(2):103–11.11. Lawn SD, Zumla AI. Tuberculosis. Lancet. 2011;378(9785):57–72.12. Sia IG, Wieland ML. Current concepts in the management of tuberculosis. Mayo Clin Proc. 2011; 86(4):348–61.13. Ulrichs T, Kaufmann SH. New insights into the function of granulomas in human tuberculosis. J Pathol. 2006; 208(2):261–9.14. Elkington PT, Friedland JS. Matrix metalloproteinases in destructive pulmonary pathology. Thorax. 2006; 61(3):259–66.15. Esmail H, Barry CE 3rd, Young DB, Wilkinson RJ. The ongoing challenge of latent tuberculosis. Philos Trans R Soc Lond B Biol Sci. 2014;369(1645):20130437.16. Hunter RL. Pathology of post primary tuberculosis of the lung: an illustrated critical review. Tuberculosis. 2011; 91(6):497–509.17. Narasimhan P, Wood J, MacIntyre CR, Mathai D. Risk factors for tuberculosis. Pulm Med. 2013; 2013:828939.18. Sharma SK, Mohan A. Tuberculosis: from an incurable scourge to a curable disease - journey over a millennium. Indian J Med Res. 2013; 137(3):455–93.19. Lawn SD, Zumla AI. Tuberculosis. Lancet. 2011; 378(9785):57–72.20. Naing C, Mak JW, Maung M, Wong SF, Kassim AI. Meta-analysis: the association between HIV infection and extrapulmonary tuberculosis. Lung. 2013; 191(1):27–34.21. Lee KS, Song KS, Lim TH, Kim PN, Kim IY, Lee BH. Adult-onset pulmonary tuberculosis: findings on chest radiographs and CT scans. AJR Am J Roentgenol. 1993; 160(4):753–8.22. Meghji J, Lesosky M, Joekes E, Banda P, Rylance J, Gordon S, et al. Patient outcomes associated with post-tuberculosis lung damage in Malawi: a prospective cohort study. Thorax. 2020; 75(3):269–78.23. Allwood BW, Byrne A, Meghji J, Rachow A, van der Zalm MM, Schoch OD, et al. Post-tuberculosis lung disease: clinical review of an under-recognised global challenge. Lancet Glob Health. 2021; 9(12): e1679–e1688.24. Harries AD, Chakaya JM, Kumar AMV, Satyanarayana S, Lin Y, Zachariah R. Post-tuberculosis lung disease: a neglected area of research and policy. Int J Tuberc Lung Dis. 2016; 20(9):1142–4.25. Gupte AN, Paradkar M, Selvaraju S, Mave V, Gupte N, Shivakumar SVBY, et al. Assessment of lung function in patients with post- tuberculosis sequelae. Int J Tuberc Lung Dis. 2019; 23(7):718–25.26. Byrne AL, Marais BJ, Mitnick CD, Lecca L, Marks GB. Tuberculosis and chronic respiratory disease: a systematic review. Int J Infect Dis. 2015; 32:138–46.27. Migliori GB, Nardell E, Yedilbayev A, D’Ambrosio L, Centis R, Tadolini M, et al. Reducing tuberculosis transmission: a consensus document. Int J Tuberc Lung Dis. 2019; 23(2):131–40.28. Meghji J, Lesosky M, Joekes E, Banda P, Rylance J, Gordon S, et al. Patient outcomes associated with post-tuberculosis lung damage in Malawi: a prospective cohort study. Thorax. 2020; 75(3):269–78.29. Byrne AL, Marais BJ, Mitnick CD, Lecca L, Marks GB. Tuberculosis and chronic respiratory disease: a systematic review. Int J Infect Dis. 2015; 32:138–46.30. Harries AD, Ade S, Burney P, Hoa NB, Schluger NW, Williams BG. Successfully treated but not fit for purpose: paying attention to chronic lung impairment after TB treatment. Int J Tuberc Lung Dis. 2019; 23(7):820–2.31. Migliori GB, Marx FM, Ambrosino N, Zampogna E, Schaaf HS, van der Zalm MM, et al. Clinical standards for the assessment, management, and rehabilitation of post-TB lung disease. Eur Respir J. 2021;57(4):2100255.32. Allwood BW, Byrne A, Meghji J, Rachow A, van der Zalm MM, Schoch OD, et al. Post-TB lung disease: approaches to improve management in low- and middle-income countries. Int J Tuberc Lung Dis. 2021; 25(11): 891–901.33. Martínez L, Cords O, Horsburgh CR Jr, Andrews JR. The risk of tuberculosis in children after close exposure: a systematic review and individual-participant meta-analysis. Lancet. 2020; 395(10228):973–84.34. Migliori GB, Marx FM, Ambrosino N, Zampogna E, Schaaf HS, van der Zalm MM, et al. Clinical standards for the assessment, management, and rehabilitation of post-TB lung disease. Eur Respir J. 2021; 57(4):2100255.35. Silva DR, Visca D, Connell DW, Alffenaar JW, Bonnett LJ, Fox GJ, et al. Long-term sequelae of pulmonary tuberculosis: a systematic review and meta-analysis. Eur Respir J. 2018;52(6):1800939.36. Jones R, Kirenga B, Katagira W, Singh S, van Zyl Smit R, Nikolayevskyy V, et al. Post-tuberculosis lung disease: A global perspective on the need for care and rehabilitation. Int J Tuberc Lung Dis. 2021;25(9):731–42.1. Osman M, van Schalkwyk C, Naidoo P, Seddon JA, Dunbar R, Dlamini SS, et al. Mortality during tuberculosis treatment in South Africa using an 8-year analysis of the national tuberculosis treatment register. Sci Rep. 2021;11(1):16427. doi:10.1038/s41598-021-95871-x2. Fondo Colombiano de Enfermedades de Alto Costo. Situación del VIH en Colombia 2023. Bogotá: Cuenta de Alto Costo; 2024. Disponible en: https://cuentadealtocosto.org/site/publicaciones/3. Odone A, Amadasi S, White RG, Cohen T, Grant AD, Houben RMGJ. The impact of antiretroviral therapy on mortality in HIV-positive people during tuberculosis treatment: a systematic review and meta-analysis. PLoS One. 2014;9(11): e112017. doi:10.1371/journal. pone.01120174. Ministerio de Salud y Protección Social. Resolución No. 227 de 2020. Por la cual se actualiza el protocolo de manejo de tuberculosis en Colombia. Bogotá: MinSalud; 2020.5. Burtle D, Marsh S, Matin N. Update on the management of patients with HIV infection in anaesthesia and critical care. BJA Educ. 2023;23(7):264–72. doi:10.1016/j.bjae.2023.03.0076. Gaviria SP, Zapata N, Villa P, Agudelo CA, Molina FJ, González MA, et al. HIV/AIDS infection in critical care: epidemiological profile and risk factors for mortality in a Colombian cohort. J Infect Dev Ctries. 2023;17(1):102–110. doi:10.3855/jidc.171007. Bell LCK, Noursadeghi M. Pathogenesis of HIV-1 and Mycobacterium tuberculosis co-infection. Nat Rev Microbiol. 2018;16(2):80–90. doi:10.1038/nrmicro.2017.1288. Sterling TR, Pham PA, Chaisson RE. HIV infection-related tuberculosis: Clinical manifestations and treatment. Clin Infect Dis. 2010;50 Suppl 3: S223–30. doi:10.1086/6514959. de Resende NH, de Miranda SS, Ceccato MDGB, Reis AMM, Haddad JPA, da Silva DI, et al. Assessment of factors associated with potential drug-drug interactions in patients with tuberculosis and HIV/AIDS. Rev Soc Bras Med Trop. 2021;54: e00742020. doi:10.1590/0037-8682-0742-202010. Cevaal PM, Bekker LG, Hermans S. TB-IRIS pathogenesis and new strategies for intervention: insights from related inflammatory disorders. Tuberculosis (Edinb). 2019;118:101858. doi:10.1016/j. tube.2019.10185811. Abay SM, Deribe K, Reda AA, Biadgilign S, Datiko D, Assefa T, et al. The effect of early initiation of antiretroviral therapy in TB/HIV-coinfected patients: a systematic review and meta- analysis. J Int Assoc Provid AIDS Care. 2015;14(6):560–70. doi:10.1177/232595741456768712. Li L, Li J, Chai C, Liu T, Li P, Qu M, et al. Association of CD4 T cell count and optimal timing of antiretroviral therapy initiation with immune reconstitution inflammatory syndrome and all-cause mortality for HIV-infected adults with newly diagnosed pulmonary tuberculosis: a systematic review and meta-analysis. Int J Clin Exp Pathol. 2021;14(2):265–77. Disponible en: http://www.ijcep.com/ files/ijcep0122456.pdf13. Abay SM, Deribe K, Reda AA, Biadgilign S, Datiko D, Assefa T, et al. The effect of early initiation of antiretroviral therapy in TB/HIV-coinfected patients: a systematic review and meta- analysis. J Int Assoc Provid AIDS Care. 2015;14(6):560–70. doi:10.1177/232595741456768714. Naidoo K, Yende-Zuma N, Padayatchi N, Naidoo K, Jithoo N, Nair G, et al. The immune reconstitution inflammatory syndrome after antiretroviral therapy initiation in patients with tuberculosis: findings from the SAPiT trial. Ann Intern Med. 2012;157(5):313–24. doi:10.7326/0003-4819-157-5-201209040-0000415. Yan S, Chen L, Wu W, Fu Z, Zhang H, Li Z, et al. Early versus delayed antiretroviral therapy for HIV and tuberculosis co-infected patients: a systematic review and meta-analysis of randomized controlled trials. PLoS One. 2015;10(5): e0127645. doi:10.1371/ journal.pone.0127645 Capítulo 3. La TB y la Enfermedad post-TB, consideraciones para su manejo en UCIChaudhry D, Tyagi D. Tuberculosis in Intensive Care Unit. Indian J Crit Care Med. 2021;25(Suppl 2): S150. doi:10.5005/JP- JOURNALS-10071-23872World Health Organization. Global Tuberculosis Report 2024. Geneva: WHO; 2024.Otu A, Hashmi M, Mukhtar AM, et al. The critically ill patient with tuberculosis in intensive care: Clinical presentations, management, and infection control. J Crit Care. 2018; 45:184-196.Galvin J, Tiberi S, Akkerman O, et al. Pulmonary tuberculosis in intensive care settings, with a focus on the use of severity scores: a multinational collaborative systematic review. Pulmonology. 2022;28(4):297-309.Chacko B, Chaudhry D, Peter JV, et al. ISCCM Position Statement on the Approach to and Management of Critically Ill Patients with Tuberculosis. Indian J Crit Care Med. 2024;28(Suppl 2): S67.Tiberi S, Torrico MM, Rahman A, et al. Managing severe tuberculosis and its sequelae: from intensive care to surgery and rehabilitation. J Bras Pneumol. 2019;45(2): e20180324.Silva DR, Menegotto DM, Schulz LF, et al. Mortality among patients with tuberculosis requiring intensive care: A retrospective cohort study. BMC Infect Dis. 2010; 10:54.Pecego AC, Amancio RT, Ribeiro C, et al. Six-month survival of critically ill patients with HIV-related disease and tuberculosis: A retrospective study. BMC Infect Dis. 2016; 16:1-9.Muthu V, Agarwal R, Dhooria S, et al. Outcome of Critically Ill Subjects with Tuberculosis: Systematic Review and Meta-Analysis. Respir Care. 2018;63(12):1541-1554.Loh WJ, Yu Y, Loo CM, et al. Factors associated with mortality among patients with active pulmonary tuberculosis requiring intensive care. Singapore Med J. 2017;58(11):656-659.Erbes R, Oettel K, Raffenberg M, et al. Characteristics and Outcomes of Patients with Active Pulmonary Tuberculosis Requiring Intensive Care Eur Respir J. 2006;27(6):1223-1228.Cui K, Mao Y, Feng S, et al. Association Between Age and the 28-Day All-Cause Mortality in Tuberculosis Complicated by Sepsis in ICU Patients: A Retrospective Cohort Study. Infect Drug Resist. 2024; 17:1879.Thomas L, Chacko B, Jupudi S, et al. Clinical Profile and Outcome of Critically Ill Patients with Tuberculosis. Indian J Crit Care Med. 2021;25(1):21.Freercks R, Gigi N, Aylward R, et al. Scope and mortality of adult medical ICU patients in an Eastern Cape tertiary hospital. South Afr J Crit Care. 2022;38(3):10.Tatar D, Senol G, Kirakli C, et al. Contributing factors to mortality rates of pulmonary tuberculosis in intensive care units. J Chin Med Assoc. 2018;81(7):605-610.Wang JL, Yin QY, Han C, et al. Risk factors for death in tuberculosis patients requiring ICU care. Epidemiol Infect. 2021; 149: e22.Huang XQ, Pan L, Pan XH, et al. The Correlation between 25-Hydroxyvitamin D3 and the Severity and Short-Term Prognosis of Pulmonary Tuberculosis. Clin Lab. 2022;68(3):559-564.Kim WY, Kim MH, Jo EJ, et al. Predicting Mortality in Patients with Tuberculous Destroyed Lung Receiving Mechanical Ventilation. Tuberc Respir Dis. 2018;81(3):247.Cui K, Mao Y, Feng S, et al. Development and Validation of a Risk Mortality Prediction Model for Patients with Pulmonary Tuberculosis Complicated by Severe Community-Acquired Pneumonia in the Intensive Care Unit. Infect Drug Resist. 2024; 17:3113.Vesteinsdottir E, Myrdal G, Sverrisson KO, Skarphedinsdottir SJ, Gudlaugsson O, Karason S. ARDS from miliary tuberculosis successfully treated with ECMO. Respir Med Case Rep. 2019; 26:165. doi:10.1016/J.RMCR.2019.01.005Agarwal R, Gupta D, Aggarwal AN, Behera D, Jindal SK. Experience with ARDS caused by tuberculosis in a respiratory intensive care unit. Intensive Care Med. 2005;31(9):1284. doi:10.1007/S00134- 005-2721-2Erdem H, Ozturk-Engin D, Tireli H, et al. Hamsi scoring in the prediction of unfavorable outcomes from tuberculous meningitis: results of Haydarpasa-II study. J Neurol. 2015;262(4):890-898. doi:10.1007/ S00415-015-7651-5Kethireddy S, Light RB, Mirzanejad Y, et al. Mycobacterium tuberculosis septic shock. Chest. 2013;144(2):474-482. doi:10.1378/chest.12-1286Angoulvant D, Mohammedi I, Duperret S, Bouletreau P. Septic shock caused by Mycobacterium tuberculosis in a non-HIV patient [3]. Intensive Care Med. 1999;25(2):238. doi:10.1007/S001340050825/ METRICSFerrand RA, Herman J, Elgalib A, Cartledge J, Miller RF. Septic shock and multi-organ failure in HIV infection-’sepsis tuberculosa gravissima’. Int J STD AIDS. 2006;17(8):562-564. doi:10.1258/095646206778145578Agarwal R, Gupta D, Handa A, Aggarwal AN. Noninvasive ventilation in ARDS caused by Mycobacterium tuberculosis: Report of three cases and review of literature [1]. Intensive Care Med. 2005;31(12):1723-1724. doi:10.1007/S00134-005-2823-X/TABLES/1Esquinas AM, Egbert Pravinkumar S, Scala R, et al. Noninvasive mechanical ventilation in high-risk pulmonary infections: a clinical review. European Respiratory Review. 2014;23(134):427. doi:10.1183/09059180.00009413Idris R, Zielbauer AS, Koepsell J, Kloka J, Wetzstein N. Extracorporeal membrane oxygenation (ECMO) in patients with tuberculosis: systematic review and meta-analysis of 43 cases. BMC Pulm Med. 2024;24(1):1-10. doi:10.1186/S12890-023-02715-X/TABLES/4Charya A V., Holden VK, Pickering EM. Management of life-threatening hemoptysis in the ICU. J Thorac Dis. 2021;13(8):5139-5158. doi:10.21037/JTD-19-3991Lin C, Chen Y, Cai D, et al. The efficacy and safety of combined therapy with endobronchial tamponade and bronchial artery embolization for massive hemoptysis. BMC Pulm Med. 2024;24(1):1-9. doi:10.1186/ S12890-024-03116-4/FIGURES/5Hsiao EI, Kirsch CM, Kagawa FT, Wehner JH, Jensen WA, Baxter RB. Utility of fiberoptic bronchoscopy before bronchial artery embolization for massive hemoptysis. American Journal of Roentgenology. 2001;177(4):861-867. doi:10.2214/ AJR.177.4.1770861/ASSET/IMAGES/10_AA1377_07.JPEGTao Y, Li J, Su R, Zhou M, Zhu H, Sun Z. The efficacy, safety, and related factors of bronchial artery embolization for hemoptysis: a systematic review and meta-analysis with subgroup analysis. Cardiovasc Diagn Ther. 2024;14(5):859-877. doi:10.21037/CDT-24- 157/COIFZahar JR, Azoulay E, Klement E, et al. Delayed treatment contributes to mortality in ICU patients with severe active pulmonary tuberculosis and acute respiratory failure. Intensive Care Med. 2001;27(3):513- 520. doi:10.1007/S001340000849/METRICSKoegelenberg CFN, Nortje A, Lalla U, et al. The pharmacokinetics of enteral antituberculosis drugs in patients requiring intensive care. S Afr Med J. 2013;103(6):394-398. doi:10.7196/SAMJ.6344Hernández-Cárdenas C, Lugo-Goytia G. Pharmacokinetics of antituberculosis drugs in critically ill patients with tuberculosis and acute respiratory failure. Crit Care. 2014;18(Suppl 1):P354. doi:10.1186/CC13544Anton C, Lemos CX, Machado FD, Bernardi RM, Freitas AA, Silva DR. Tuberculosis in the intensive care unit: alternative treatment regimens and association with mortality. Tropical Medicine & International Health. 2021;26(1):111-114. doi:10.1111/TMI.13511Ruslami R, Ganiem AR, Dian S, et al. Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open- label, randomised controlled phase 2 trial. Lancet Infect Dis. 2013;13(1):27-35. doi:10.1016/S1473-3099(12)70264-5Boeree MJ, Heinrich N, Aarnoutse R, et al. High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi- arm, multi-stage randomised controlled trial. Lancet Infect Dis. 2017;17(1):39-49. doi:10.1016/S1473-3099(16)30274-2Jothimani D, Sachan D, Saha S, Kalyamoorthy I, Rela M. 4. Role of therapeutic plasma exchange (TPE) in patients with drug- induced liver injury. J Clin Exp Hepatol. 2018 ;8:S83. doi:10.1016/j. jceh.2018.06.425Prasad K, Singh MB, Ryan H. Corticosteroids for managing tuberculous meningitis. Cochrane Database of Systematic Reviews. 2016;2016(4). doi:10.1002/14651858.CD002244.PUB4/MEDIA/ CDSR/CD002244/IMAGE_N/NCD002244-CMP-004-01.PNG1. World Health Organization. Global tuberculosis report. Geneva, Switzerland: WHO; 2023. https://www.who.int/es/news-room/fact- sheets/detail/tuberculosis.2. Tobín MJ. Ventilación mecánica. 2. ed. Nueva York: McGraw-Hill; 2013.3. Kim S, Kim H, Kim WJ, et al. Mortality and predictors in pulmonary tuberculosis with respiratory failure requiring mechanical ventilation. Int J Tuberc Lung Dis. 2016;20(5):524–9.4. Karakas A, Turhan V, Esquinas AM. Reasons for high mortality rates in patients with pulmonary tuberculosis needing mechanical ventilation. Int J Tuberc Lung Dis. 2016;20(10):1416–9.5. Agarwal R, Gupta D, Aggarwal AN, et al. Experience with ARDS caused by tuberculosis in a respiratory intensive care unit. Intensive Care Med. 2005; 31:1284–7.6. Alsayed SSR, Gunosewoyo H. Tuberculosis: Pathogenesis, Current Treatment Regimens and New Drug Targets. Int. J. Mol. Sci. 2023; 24(6): 5202.7. Aso H, Kondoh Y, Taniguchi H, Kimura T, Nishiyama O, Kato K, et al. Noninvasive ventilation in patients with acute exacerbation of pulmonary tuberculosis sequelae. Intern Med. 2010;49(19):2077– 83.8. Muñoz J, Cedeño JA, Castañeda GF, Visedo LC. Personalized ventilation adjustment in ARDS: A systematic review and meta- analysis of image, driving pressure, transpulmonary pressure, and mechanical power. Heart Lung. 2024; 68:305–15.9. Gong Y, Ponnapalli A, Hafeez K, Soubani AO. Noninvasive ventilation for respiratory failure: When does it work and when it does not? Am J Med Sci. 2025;369(5):547–55.10. Davidson J, Chesen B, Kumar S, Shayowitz DJ. Hospital Practices for Respiratory Isolation for Patients with Suspected Tuberculosis and Potential Application of Prediction Models. Cureus. 2022;14(12).11. Hashemian SM, Khoundabi B, Bahrami A, Jamaati H, Varahram M, Saljoughi L, et al. Optimal Positive End-expiratory Pressure Levels in Tuberculosis-associated Acute Respiratory Distress Syndrome. Int J Mycobacteriol. 2024;13(3):247–51.12. Muthu V, Dhooria S, Aggarwal AN, Behera D, Sehgal IS, Agarwal R. Acute Respiratory Distress Syndrome Due To Tuberculosis in a Respiratory ICU Over 16 years. Crit Care Med. 2017;45(10): e1087– 90.13. Hamahata N, Pinsky MR. Heart-Lung Interactions. Semin Respir Crit Care Med. 2023;44(5):650–60.14. Northam KA, Phillips KM. Sedation in the ICU. NEJM Evid. 2024;3(11).15. Kyo M, Shimatani T, Hosokawa K, Taito S, Kataoka Y, Ohshimo S, et al. Patient-ventilator asynchrony, impact on clinical outcomes and effectiveness of interventions: a systematic review and meta- analysis. J Intensive Care. 2021;9(1):50.1. World Health Organization. Global tuberculosis report 2021. Geneva: WHO; 2021.2. García-Rivero R, Ramírez-López J, Sánchez-Ortega A. Trayectorias de atención en tuberculosis: interacciones entre cultura, enfermedad y atención en salud. Rev Fac Nac Salud Pública. 2019;37(3):384–94.3. Varela B, Sánchez F, Rincón C. Factores sociales asociados a la tuberculosis: una revisión narrativa. Rev Cienc Salud. 2023;21(2):121–36.4. Perlaza R, Cardona S, Roldán J. Determinantes sociales y abandono del tratamiento en tuberculosis pulmonar. Rev Salud Pública. 2023;25(1):29–39.5. Bonilla-Asalde C, Rivera-Lozada O, Rivera-Lozada B. Estigma y tuberculosis: una barrera para la adherencia terapéutica. Rev Peru Med Exp Salud Publica. 2021;38(4):618–23.6. Upegui-Arango LD, Orozco L. Perspectivas de adherencia terapéutica en TB: desafíos y oportunidades. Biomédica. 2019;39(Supl.1):90–100.7. Plata-Casas JP. Tuberculosis multirresistente: retos actuales para el sistema de salud. Rev Gerenc Polit Salud. 2015;14(29):36–47.8. Li J. Addressing challenges in TB treatment adherence: a review. Int J Tuberc Lung Dis. 2021;25(4):299–310.9. Antolinez-Figueroa D, Castañeda E, Marín MJ. Significados sociales del diagnóstico de tuberculosis en Colombia. Salud Colect. ,2022;18: e3996.10. Instituto Nacional de Salud. Informe de evento tuberculosis 2021. Bogotá: INS; 2023.11. Castro M, Camarena A, Fernández M. Barreras sociales en el tratamiento de la tuberculosis: un enfoque desde los determinantes sociales. Rev. Salud Pública (Bogotá). 2020;22(3):e220304.12. Munro SA, Lewin SA, Smith HJ, Engel ME, Fretheim A, Volmink J. Patient adherence to tuberculosis treatment: a systematic review of qualitative research. PLoS Med. 2007;4(7): e238.13. Salaverry O. Antropología médica: una mirada crítica desde la salud. Rev Peru Med Exp Salud Publica. 2017;34(2):339–45.14. Cornejo M, Mendoza F, Rojas C. Historia de vida y construcción de sentido: reflexiones metodológicas para la investigación cualitativa. Psykhe (Santiago). 2008;17(2):29–39.1. Brown J, Capocci S, Smith C, Morris S, Abubakar I, Lipman M. Health status and quality of life in tuberculosis. Int J Infect Dis. 2015; 32:68– 75. Available from: http://dx.doi.org/10.1016/j.ijid.2014.12.0452. World Health Organization. WHOQOL: Measuring quality of life. Geneva: WHO; 1997.3. Fernández-López JA, Fernández-Fidalgo M, Cieza A. Los conceptos de calidad de vida, salud y bienestar son analizados desde la perspectiva de la clasificación internacional del funcionamiento (CIF). Rev. Esp. Salud Pública. 2010;84(2):169–84.4. Samuel R, Natesan S, Bangera MK. Quality of life and associated factors in pulmonary tuberculosis patients. Indian J Tuberc. 2023;70(2):214–21. Available from: https://doi.org/10.1016/j. ijtb.2022.05.0055. Wang H, Gu J, Zhang L, Song Y. Assessing the quality of life in patients with drug-resistant tuberculosis: a cross-sectional study. BMC Pulm Med. 2024;24(1):1–11.6. Aggarwal AN. Quality of life with tuberculosis. J Clin Tuberc Other Mycobact Dis. 2019; 17:100121. Available from: https://doi. org/10.1016/j.jctube.2019.1001217. Bauer M, Leavens A, Schwartzman K. A systematic review and meta- analysis of the impact of tuberculosis on health-related quality of life. Qual Life Res. 2013;22(8):2213–35.8. Lutfian L, Azizah A, Wardika IJ, Wildana F, Maulana S, Wartakusumah R. The role of family support in medication adherence and quality of life among tuberculosis patients: A scoping review. Japan J Nurs Sci. 2025;22(1):1–11.9. Alene KA, Clements ACA, McBryde ES, Jaramillo E, Lönnroth K, Shaweno D, et al. Mental health disorders, social stressors, and health-related quality of life in patients with multidrug-resistant tuberculosis: A systematic review and meta-analysis. J Infect. 2018;77(5):357–67. Available from: https://doi.org/10.1016/j. jinf.2018.07.00710. Ramachandran R, Dumitrescu A, Baiceanu D, Popa C, Dragomir A, Mahler B, et al. Impact of drug-resistant tuberculosis on socio- economic status, quality of life, and psychological well-being of patients in Bucharest, Romania: a prospective cohort study. J Heal Popul Nutr. 2024;43(1).11. Meghji J, Gregorius S, Madan J, Chitimbe F, Thomson R, Rylance J, et al. The long-term effect of pulmonary tuberculosis on income and employment in a low-income, urban setting. Thorax. 2021;76(4):387–95.12. Abdulelah J, Azhar S, Sulaiman S, Hassali MA, et al. Development and psychometric properties of a tuberculosis-specific multidimensional health-related quality-of-life measure for patients with pulmonary tuberculosis. Value Health Reg Issues. 2015; 6:53–9. Available from: http://dx.doi.org/10.1016/j.vhri.2015.03.00613. Vernon A, Fielding K, Savic R, Dodd L, Nahid P. The importance of adherence in tuberculosis treatment clinical trials and its relevance in explanatory and pragmatic trials. PLoS Med. 2019;16(12): e1002884.1. Allwood BW, van der Zalm MM, Amaral AFS, Byrne A, Datta S, Egere U, et al. Post-tuberculosis lung health: perspectives from the First International Symposium. Int J Tuberc Lung Dis. 2020;24(8):820– 8.2. Meghji J, Gregorius S, Madan J, Chitimbe F, Thomson R, Rylance J, et al. The long-term effect of pulmonary tuberculosis on income and employment in a low-income, urban setting. Thorax. 2021; 76(4):387–95.3. World Health Organization. WHO consolidated guidelines on tuberculosis. Module 5: Management of tuberculosis in children and adolescents. Geneva: WHO; 2022.4. Byrne AL, Marais BJ, Mitnick CD, Lecca L, Marks GB. Tuberculosis and chronic respiratory disease: a systematic review. Int J Infect Dis. 2015; 32:138–46.5. Ramos LM, Sulmonett N, Ferreira CS, Henriques JF, Oliveira JR, da Costa CH. Functional profile of patients with tuberculosis sequelae in a university hospital. J Bras Pneumol. 2006;32(1):43–7.6. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six- minute walk test. Am J Respir Crit Care Med. 2002;166(1):111–7. Hnizdo E, Singh T, Churchyard G. Chronic pulmonary function impairment caused by initial and recurrent pulmonary tuberculosis following treatment. Thorax. 2000; 55(1):32–8.8. Gupte AN, Paradkar M, Selvaraju S, et al. Assessment of post- tuberculosis lung impairment using spirometry and 6-minute walk test: a prospective cohort study. BMC Pulm Med. 2021;21(1):234.9. Chaves Torres NM, Quijano Rodríguez JJ, Porras Andrade MJ, Arrieta JH. The impact of tuberculosis on health-related quality of life: a follow-up study. Arch Bronconeumol. 2022;58(5):386–92.10. Meghji J, Mortimer K, Agusti A, et al. Improving lung health in low-income and middle-income countries: from challenges to solutions. Lancet. 2021;397(10277):928–40.11. Allwood BW, Byrne A, Meghji J, et al. Post-tuberculosis lung disease: clinical review of an under-recognised global challenge. Respiration. 2021;100(8):751–63.12. de Albuquerque MFP, Campelo ARL, de Souza WV, et al. Post- tuberculosis pulmonary function impairment: a systematic review and meta-analysis. Chest. 2023;163(5):1120–34.13. Holland AE, Spruit MA, Troosters T, et al. An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J. 2014;44(6):1428–46.14. Tudor Car L, van Velthoven MH, Brusamento S, et al. Telehealth strategies for the delivery of pulmonary rehabilitation in chronic respiratory diseases: a systematic review and meta-analysis. NPJ Prim Care Respir Med. 2022;32(1):5.15. Visca D, Zampogna E, Sotgiu G, et al. Pulmonary rehabilitation is effective in patients with tuberculosis pulmonary sequelae. Eur Respir J. 2021;57(3):2002566.16. Ahmed AE, Al-Hajjaj MS, Al-Harbi AS. Pulmonary function and 6-minute walk test in patients with post-tuberculosis pulmonary impairment. Saudi Med J. 2020;41(9):976–81.17. Organización Panamericana de la Salud (OPS). Evaluación del seguimiento post-tratamiento de tuberculosis pulmonar en América Latina. Informe técnico 2023.18. Amaral AF, Coton S, Kato B, Tan WC, Studnicka M, Janson C, et al. Tuberculosis associates with both airflow obstruction and low lung function: BOLD results. Eur Respir J. 2015;46(4):1104–12. doi:10.1183/13993003.02325-201419. Meghji J, Lesosky M, Joekes E, Banda P, Rylance J, Gordon S, et al. Patient outcomes associated with post-tuberculosis lung damage in Malawi: a prospective cohort study. Thorax. 2020;75(3):269– 78. doi:10.1136/thoraxjnl-2019-21380820. Allwood BW, van der Zalm MM, Amaral AFS, Byrne A, Datta S, Egere U, et al. Post-tuberculosis lung health: perspectives from the First International Symposium. Int J Tuberc Lung Dis. 2020;24(8):820– 8. doi:10.5588/ijtld.20.014721. Migliori GB, Marx FM, Ambrosino N, Zampogna E, Visca D, Centis R. Clinical standards for the assessment, management and rehabilitation of post-TB lung disease. Int J Tuberc Lung Dis. 2021;25(10):797–813. doi:10.5588/ijtld.21.042722. Meghji J, Gregorius S, Madan J, Chitimbe F, Thomson R, Rylance J, et al. The long-term effect of pulmonary tuberculosis on income and employment in a low-income, urban setting. Thorax. 2021;76(4):387–95. doi:10.1136/thoraxjnl-2020-21533823. Migliori GB, Marx FM, Ambrosino N, Zampogna E, Visca D, Centis R. Clinical standards for the assessment, management and rehabilitation of post-TB lung disease. Int J Tuberc Lung Dis. 2021;25(10):797–813. doi:10.5588/ijtld.21.042724. World Health Organization. WHO consolidated guidelines on tuberculosis. Module 5: management of tuberculosis in children and adolescents. Geneva: WHO; 2022. Available from: https:// www.who.int/publications/i/item/97892400604721. Allwood BW, Byrne A, Meghji J, et al. Post-tuberculosis lung disease: clinical review of an under-recognised global challenge. Lancet Glob Health. 2021;9(12): e1679–e1688.2. Meghji J, Lesosky M, Joekes E, et al. Patient outcomes associated with post-tuberculosis lung damage in Malawi: a prospective cohort study. Thorax. 2020;75(3):269–78.3. Chaudhry D, Tyagi D. Tuberculosis in Intensive Care Unit. Indian J Crit Care Med. 2021;25(Suppl 2): S150.4. Mohr-Holland E, et al. Quality of life and functional status in TB survivors: A neglected dimension of post-TB care. Int J Tuberc Lung Dis. 2022;26(1):15–23.5. Seneviratne S, et al. Validation of FACIT-TB for assessing quality of life in post-TB patients. Appl Res Qual Life. 2022;17(2):579–92.610 - Medicina y salud::616 - EnfermedadesEnfermedades transmisiblesInfecciones respiratoriasMedicina - Investigaciones3. Ciencias Médicas y de la SaludEnfermedades infecciosasEnfermedades respiratoriasTuberculosisMedicina – InvestigacionesODS 3: Salud y bienestar. Garantizar una vida sana y promover el bienestar de todos a todas las edadesEnfermedad pulmonar post-tuberculosis (PTLD): perspectivas clínicas, funcionales y socialesLibroinfo:eu-repo/semantics/acceptedVersionhttp://purl.org/coar/resource_type/c_2f33Textinfo:eu-repo/semantics/bookPereira, Risaralda, ColombiaComunidad académica y científica, Estudiantes, Docentes, InvestigadoresPublicationORIGINALEnfermedad_Pulmonar_Post_Tuberculosis_PTLD _Perspectivas _clinicas_funcionales_y_sociales.pdfEnfermedad_Pulmonar_Post_Tuberculosis_PTLD _Perspectivas _clinicas_funcionales_y_sociales.pdfapplication/pdf12775208https://repositorio.utp.edu.co/bitstreams/7bc01e8e-bc17-4e94-b521-c8b6ae93eb22/downloade7bdd95f80e6d2baa0469f17639b634cMD51LICENSElicense.txtlicense.txttext/plain; charset=utf-815543https://repositorio.utp.edu.co/bitstreams/90f427ab-7b71-4c2a-8ddc-ff52f584ce5d/download73a5432e0b76442b22b026844140d683MD52THUMBNAILImagen1.pngimage/png620716https://repositorio.utp.edu.co/bitstreams/5b0e47e6-eb38-4dc3-ae03-939c25b7bf0f/downloada76beb2e69e5679416852906655cfca6MD53Enfermedad_Pulmonar_Post_Tuberculosis_PTLD _Perspectivas _clinicas_funcionales_y_sociales.pdf.jpgEnfermedad_Pulmonar_Post_Tuberculosis_PTLD _Perspectivas _clinicas_funcionales_y_sociales.pdf.jpgGenerated Thumbnailimage/jpeg10861https://repositorio.utp.edu.co/bitstreams/ce1d3796-3fa4-4fda-95d3-a7740df40ee0/download8bde279550b8a5ed2ef245a0fedac1deMD55TEXTEnfermedad_Pulmonar_Post_Tuberculosis_PTLD _Perspectivas _clinicas_funcionales_y_sociales.pdf.txtEnfermedad_Pulmonar_Post_Tuberculosis_PTLD _Perspectivas _clinicas_funcionales_y_sociales.pdf.txtExtracted texttext/plain101593https://repositorio.utp.edu.co/bitstreams/66e69135-ef5b-4e1a-80ab-4ad7b432a8e3/download48d49739279e299492712323a337d915MD5411059/16449oai:repositorio.utp.edu.co:11059/164492025-11-12 15:13:28.633https://creativecommons.org/licenses/by-nc-nd/4.0/Manifiesto (Manifestamos) en este documento la voluntad de autorizar a la Biblioteca Jorge Roa Martínez de la Universidad Tecnológica de Pereira la publicación en el Repositorio institucional (http://biblioteca.utp.edu.co), la versión electrónica de la OBRA titulada: La Universidad Tecnológica de Pereira, entidad académica sin ánimo de lucro, queda por lo tanto facultada para ejercer plenamente la autorización anteriormente descrita en su actividad ordinaria de investigación, docencia y publicación. La autorización otorgada se ajusta a lo que establece la Ley 23 de 1982. Con todo, en mi (nuestra) condición de autor (es) me (nos) reservo (reservamos) los derechos morales de la OBRA antes citada con arreglo al artículo 30 de la Ley 23 de 1982. En concordancia suscribo (suscribimos) este documento en el momento mismo que hago (hacemos) entrega de mi (nuestra) OBRA a la Biblioteca “Jorge Roa Martínez” de la Universidad Tecnológica de Pereira. Manifiesto (manifestamos) que la OBRA objeto de la presente autorizaciónopen.accesshttps://repositorio.utp.edu.coRepositorio de la Universidad Tecnológica de Pereirabdigital@metabiblioteca.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

Publicaciones similares